Volume 8, issue 1, December 2022
20 articles in this issue
-
-
Meeting report: Advancing accelerated regulatory review with Real-Time Oncology Review (RTOR), Project Orbis, and the Product Quality Assessment Aid
Authors (first, second and last of 17)
This is part of 1 collection: -
Formulation mitigations for particle formation induced by enzymatic hydrolysis of polysorbate 20 in protein-based drug products: insights from a full-factorial longitudinal study
Authors (first, second and last of 8)
This is part of 1 collection:
-
Verification of nanoparticle formation, skin permeation, and apoptosis using nobiletin as a methoxyflavonoid derivative
Authors (first, second and last of 5)
This is part of 1 collection:
-
Results from in vitro and in vivo studies evaluating the bioavailability, effects of food, and administration as crushed tablet suspension on vericiguat pharmacokinetics
Authors (first, second and last of 6)
This is part of 1 collection:
-
Stability of levothyroxine tablets in blister packaging versus bottles and vials under simulated in-use conditions
Authors
This is part of 1 collection:
-
Technical transfer and commercialisation of lyophilised biopharmaceuticals — application of lyophiliser characterisation and comparability
Authors (first, second and last of 5)
This is part of 1 collection:
-
Correction: Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL TM)
Authors (first, second and last of 7)
-
PLGA-based nanoparticles for the treatment of cancer: current strategies and perspectives
Authors (first, second and last of 5)
This is part of 1 collection:
-
Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL TM)
Authors (first, second and last of 7)
This is part of 1 collection:
-
Utilizing cross-product prior knowledge to rapidly de-risk chemical liabilities in therapeutic antibody candidates
Authors
This is part of 1 collection:
-
Molecular docking assisted exploration on solubilization of poorly soluble drug remdesivir in sulfobutyl ether-tycyclodextrin
Authors (first, second and last of 12)
This is part of 1 collection:
-
Heat pre-treatment can abolish anti-drug antibody interference in ligand binding pharmacokinetic assays
Authors
This is part of 1 collection:
-
Pharmacokinetic and pharmacodynamic analyses of terlipressin in patients with hepatorenal syndrome
Authors
This is part of 1 collection:
-
Understanding the implication of Kawakita model parameters using in-die force-displacement curve analysis for compacted and non-compacted API powders
Authors (first, second and last of 5)
This is part of 1 collection:
-
The degradation of poloxamer 188 in buffered formulation conditions
Authors (first, second and last of 10)
This is part of 1 collection:
-
Therapeutic effects of dracocephalum heterophyllum in collagen-induced arthritis
Authors (first, second and last of 5)
This is part of 1 collection:
-
Impact of charge patches on tumor disposition and biodistribution of therapeutic antibodies
Authors (first, second and last of 11)
This is part of 1 collection:
-
Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report
Authors (first, second and last of 15)
This is part of 1 collection:
-
Development and validation of a headspace GC-MS method to evaluate the interconversion of impurities and the product quality of liquid hand sanitizers
Authors (first, second and last of 7)
This is part of 1 collection:
